Stockscreener 앱 받기
8.471
2.46%
-0.214
시간 외 거래:
8.47
-0.0010
-0.01%
전일 마감가:
$8.685
열려 있는:
$8.9709
하루 거래량:
55,115
Relative Volume:
0.49
시가총액:
$26.93M
수익:
-
순이익/손실:
$-68.80M
주가수익비율:
-7.2402
EPS:
-1.17
순현금흐름:
$-59.06M
1주 성능:
+6.55%
1개월 성능:
+19.99%
6개월 성능:
+2,241%
1년 성능:
+1,336%
1일 변동 폭
$8.00
$9.00
1주일 범위
$7.84
$9.00
52주 변동 폭
$0.257
$9.00
Passage Bio Inc Stock (PASG) Company Profile
명칭
Passage Bio Inc
전화
(267) 866-0312
주소
ONE COMMERCE SQUARE, PHILADELPHIA, PA
PASG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
8.471 | 27.61M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-29 | 재개 | Wedbush | Outperform |
| 2024-09-03 | 개시 | Rodman & Renshaw | Buy |
| 2022-03-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-01-19 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-07-01 | 개시 | Raymond James | Outperform |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-03-04 | 업그레이드 | Goldman | Neutral → Buy |
| 2021-02-04 | 개시 | Guggenheim | Buy |
| 2021-01-25 | 개시 | Wedbush | Outperform |
| 2021-01-04 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-12-11 | 개시 | Citigroup | Neutral |
| 2020-08-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-06-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-25 | 개시 | Chardan Capital Markets | Buy |
| 2020-03-24 | 개시 | Cowen | Outperform |
| 2020-03-24 | 개시 | Goldman | Buy |
| 2020-03-24 | 개시 | JP Morgan | Overweight |
모두보기
Passage Bio Inc 주식(PASG)의 최신 뉴스
What the charts say about Passage Bio Inc. todayWeekly Risk Report & High Yield Equity Trading Tips - newser.com
How to build a custom watchlist for Passage Bio Inc.July 2025 Drop Watch & Free Weekly Watchlist of Top Performers - newser.com
Full technical analysis of Passage Bio Inc. stockWeekly Profit Analysis & Real-Time Chart Pattern Alerts - newser.com
Key resistance and support levels for Passage Bio Inc.July 2025 Sentiment & Detailed Earnings Play Strategies - newser.com
What analysts say about Passage Bio Inc stockTechnical Pattern Recognition & Consistently Superior Profits - earlytimes.in
Passage Bio Inc. stock daily chart insightsTake Profit & Weekly Watchlist of Top Performers - newser.com
How buybacks impact Passage Bio Inc. stock valueTrade Risk Report & AI Driven Stock Reports - newser.com
Passage Bio Inc Stock Analysis and ForecastTrend Following Strategies & Rapid Portfolio Expansion - earlytimes.in
Is it too late to sell Passage Bio Inc.Bull Run & Weekly High Momentum Picks - newser.com
Is Passage Bio Inc. stock poised for growthWeekly Risk Report & Safe Capital Preservation Plans - newser.com
Is Passage Bio Inc. reversing from oversold territory2025 Pullback Review & High Accuracy Trade Signal Alerts - newser.com
Passage Bio (NASDAQ:PASG) Trading Up 1.8% – Time to Buy? - Defense World
Is Passage Bio Inc a good long term investmentMACD Histogram Signals & Investment Risk Management Tips - earlytimes.in
How institutional ownership impacts Passage Bio Inc. stockWeekly Trend Report & Safe Swing Trade Setups - newser.com
GM1 Gangliosidosis Market: Epidemiology, Therapies, Companies – DelveInsight | Featuring Passage Bio Inc., Gain Therapeutics, Sio Gene Therapies - The Globe and Mail
GM1 Gangliosidosis Market: Epidemiology, Therapies, - openPR.com
Retail Surge: Can Passage Bio Inc ride the EV waveWeekly Trading Summary & High Accuracy Trade Signal Alerts - خودرو بانک
Can machine learning forecast Passage Bio Inc. recoveryJuly 2025 Final Week & Free Expert Approved Momentum Trade Ideas - newser.com
Should you wait for a breakout in Passage Bio Inc.2025 Key Highlights & High Accuracy Buy Signal Tips - newser.com
What earnings revisions data tells us about Passage Bio Inc.July 2025 Opening Moves & Low Risk Entry Point Guides - newser.com
Using AI based signals to follow Passage Bio Inc.Portfolio Performance Report & Reliable Entry Point Trade Alerts - newser.com
Passage Bio Inc (PASG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Passage Bio Inc 주식 (PASG) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 10% Owner |
Sep 15 '25 |
Buy |
6.99 |
11,900 |
83,175 |
623,704 |
| Lynx1 Capital Management LP | 10% Owner |
Sep 11 '25 |
Buy |
6.96 |
325 |
2,261 |
592,021 |
| Lynx1 Capital Management LP | 10% Owner |
Jul 24 '25 |
Buy |
5.71 |
66,423 |
379,455 |
591,696 |
| Lynx1 Capital Management LP | 10% Owner |
Jul 23 '25 |
Buy |
5.74 |
49,302 |
283,033 |
525,273 |
| Lynx1 Capital Management LP | 10% Owner |
Jul 22 '25 |
Buy |
5.44 |
13,123 |
71,338 |
475,971 |
5.74%
자본화:
|
볼륨(24시간):